Cancer risk prediction models: a workshop on development, evaluation, and application (Q44065523)

29 November 2017

Cancer risk prediction models: a workshop on development, evaluation, and application (English)

1 reference

29 November 2017

0 references

5

1 reference

29 November 2017

Rachel Ballard-Barbash

series ordinal

6

object named as

Rachel Ballard-Barbash

1 reference

29 November 2017

2

Daniela Seminara

1 reference

29 November 2017

4

Patricia Hartge

1 reference

29 November 2017

7

Ruth M Pfeiffer

1 reference

29 November 2017

Andrew N Freedman

1

1 reference

29 November 2017

Mitchell H Gail

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Journal of the National Cancer Institute

29 November 2017

1 reference

29 November 2017

97

1 reference

29 November 2017

10

1 reference

29 November 2017

715-723

1 reference

Risk of familial breast cancer

29 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Nurses' health study: log-incidence mathematical model of breast cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Estimation of individualized probabilities of developing breast cancer for Japanese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Variations in lung cancer risk among smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

A general cardiovascular risk profile: The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Assessment and comparison of prognostic classification schemes for survival data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

The BOADICEA model of genetic susceptibility to breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI128

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJI128

1 reference

29 November 2017

1 reference